NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate
In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions
Prostate Cancer Prevention Trial Begins At 222 U.S. Sites
Duke Physician, BM, Patients, Lobby For Reimbursement
Greenpeace Report Says Chemicals Causing Breast Cancers
DCT Board Okays Recompetition of Drug Discovery Groups
NCI Communications Office to contract Media Campaigns


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









